News

Remote work policy: Atlassian employees can work from home permanently. BELAY is a virtual staffing solutions company that ...
The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...
Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a ...
In a report released today, from Oppenheimer maintained a Buy rating on Amgen, with a price target of $380.00. The company’s shares closed yesterday at $300.08. Elevate Your Inv ...
Truist Financial analyst Srikripa Devarakonda maintained a Hold rating on Amgen today. The company’s shares closed yesterday at $300.08. Elevate Your Investing Strategy: Take ad ...
The Children's and Youth Life Science Education Program 'Grow-up, Bio-up Season 5 (hereinafter referred to as Grow-up, Bio-up ...
Amgen Inc. reported a robust quarterly performance, surpassing analyst expectations with a notable revenue increase of 9.4%. ...